Elevation Point Wealth Partners LLC bought a new position in Merck KGaA (OTCMKTS:MKGAF - Free Report) during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 145,564 shares of the company's stock, valued at approximately $18,787,000. Elevation Point Wealth Partners LLC owned about 0.11% of Merck KGaA as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently bought and sold shares of MKGAF. Frazier Financial Advisors LLC purchased a new position in Merck KGaA during the second quarter worth approximately $25,000. Rakuten Securities Inc. acquired a new stake in shares of Merck KGaA during the 2nd quarter worth $27,000. Bard Associates Inc. purchased a new position in shares of Merck KGaA in the 2nd quarter worth $60,000. Kilter Group LLC purchased a new position in shares of Merck KGaA in the 2nd quarter worth $62,000. Finally, Addison Advisors LLC acquired a new position in Merck KGaA in the second quarter valued at $90,000. Institutional investors and hedge funds own 0.10% of the company's stock.
Merck KGaA Price Performance
MKGAF stock opened at $163.21 on Friday. The stock has a 50-day moving average price of $162.62 and a two-hundred day moving average price of $148.46. Merck KGaA has a 12-month low of $116.68 and a 12-month high of $175.56. The company has a current ratio of 1.31, a quick ratio of 0.84 and a debt-to-equity ratio of 0.27. The company has a market cap of $21.09 billion, a PE ratio of 24.92 and a beta of 0.96.
Merck KGaA Company Profile
(
Free Report)
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company's operations are organized mainly into three businesses.
Featured Articles
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF - Free Report).
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
